4.7 Article

Role of neurotrophins on dermal fibroblast survival and differentiation

Journal

JOURNAL OF CELLULAR PHYSIOLOGY
Volume 227, Issue 3, Pages 1017-1025

Publisher

WILEY-BLACKWELL
DOI: 10.1002/jcp.22811

Keywords

-

Ask authors/readers for more resources

Neurotrophins (NTs) belong to a family of growth factors that play a critical role in the control of skin homeostasis. NTs act through the low-affinity receptor p75NTR and the high-affinity receptors TrkA, TrkB, and TrkC. Here we show that dermal fibroblasts (DF) and myofibroblasts (DM) synthesize and secrete all NTs and express NT receptors. NTs induce differentiation of DF into DM, as shown by the expression of a-SMA protein. The Trk inhibitor K252a, TrkA/Fc, TrkB/Fc, or TrkC/Fc chimera prevents DF and DM proliferation. In addition, p75NTR siRNA inhibits DF proliferation, indicating that both NT receptors mediate DF proliferation induced by endogenous NTs. Autocrine NTs also induce DF migration through p75NTR and Trk, as either silencing of p75NTR or Trk/Fc chimeras prevent this effect, in absence of exogenous NTs. Finally, NGF or BDNF statistically increase the tensile strength in a dose dependent manner, as measured in a collagen gel through the GlaSbox device. Taken together, these results indicate that NTs exert a critical role on fibroblast and could be involved in tissue re-modeling and wound healing. J. Cell. Physiol. 227: 10171025, 2012. (C) 2011 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway

Deepti Bajpai, Spencer Mehdizadeh, Akihiko Uchiyama, Yuta Inoue, Andrew Sawaya, Andrew Overmiller, Stephen R. Brooks, Kowser Hasneen, Meghan Kellett, Elisabetta Palazzo, Sei-ichiro Motegi, Stuart H. Yuspa, Christophe Cataisson, Maria Morasso

Summary: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, with disruption of keratinocyte proliferation and differentiation playing a role in its development. DLX3, a transcription factor, is found to be associated with higher grade tumors and poor patient survival in cSCC. Studies on mice deficient in Dlx3 show that Dlx3 may function as a tumor suppressor in skin tumorigenesis, with potential therapeutic implications targeting the EGFR-ERBB2 pathway.

ONCOGENE (2021)

Article Dermatology

Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway

Marika Quadri, Antonella Comitato, Elisabetta Palazzo, Natascia Tiso, Andreas Rentsch, Giovanni Pellacani, Alessandra Marconi, Valeria Marigo

Summary: Despite ongoing drug resistance mechanisms in metastatic melanoma, utilizing two polymeric-linked dimeric cGMP analogs as protein kinase G activators demonstrated significant anti-cancer effects, with PA5 showing the most potent inhibitory impact on melanoma cells. By interfering with the EGF pathway, PA5 reduced EGFR phosphorylation and activated, phosphorylated forms of protein kinase B and extracellular signal-regulated kinase 1/2 in melanoma cells, highlighting its potential as a therapeutic strategy for melanoma.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Dermatology

In Vivo Melanoma Cell Morphology Reflects Molecular Signature and Tumor

Alessandra Marconi, Marika Quadri, Francesca Farnetani, Silvana Ciardo, Elisabetta Palazzo, Roberta Lotti, Anna Maria Cesinaro, Luca Fabbiani, Cristina Vaschieri, Mario Puviani, Cristina Magnoni, Shaniko Kaleci, Carlo Pincelli, Giovanni Pellacani

Summary: In this study, four distinct melanoma subtypes were identified using reflectance confocal microscopy, each with a specific biomolecular profile and biological behavior associated with tumor aggressiveness.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Review Medicine, General & Internal

Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models

Marika Quadri, Alessandra Marconi, Simran K. Sandhu, Alexi Kiss, Tatiana Efimova, Elisabetta Palazzo

Summary: Cutaneous Squamous Cell Carcinoma (cSCC) is a common type of skin cancer. Various in vitro and in vivo models, including three-dimensional models, have been developed to study its development and invasion. While these models contribute to cancer research, animal models are still needed to address certain issues.

FRONTIERS IN MEDICINE (2022)

Editorial Material Medicine, General & Internal

Editorial: New tools and molecular advances in hyperproliferative skin disorders

Marika Quadri, Cristina Pellegrini, Tatiana Efimova, Elisabetta Palazzo

FRONTIERS IN MEDICINE (2022)

Article Cell & Tissue Engineering

Isolation of an Early Transit Amplifying Keratinocyte Population in Human Epidermis: A Role for the Low Affinity Neurotrophin Receptor CD271

Roberta Lotti, Elisabetta Palazzo, Marika Quadri, Marc Dumas, Sylvianne Schnebert, Diego Biondini, Maria Anastasia Bianchini, Carine Nizard, Carlo Pincelli, Alessandra Marconi

Summary: ETA cells represent the first KSC progenitor with exclusive features, and CD271 identifies and modulates ETA cells, thus participating in the early differentiation and regenerative capacity of the human epidermis.

STEM CELLS (2022)

Article Oncology

CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

Marika Quadri, Natascia Tiso, Francesco Musmeci, Maria I. I. Morasso, Stephen R. R. Brooks, Luca Reggiani Bonetti, Rossana Panini, Roberta Lotti, Alessandra Marconi, Carlo Pincelli, Elisabetta Palazzo

Summary: This study found differential expression of CD271 in low-risk and high-risk cSCC tumors, and demonstrated that CD271 activity can decrease the proliferation and invasiveness of cSCC, while promoting tumor cell differentiation. CD271 also inhibits the metastatic process of cSCC and increases sensitivity to therapy. Therefore, CD271 may be a promising target for future pharmaceutical development.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Article Immunology

Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models

Roberta Lotti, Jennifer E. Hundt, Ralf J. Ludwig, Brydon Bennett, Antonino Amato, Alessandra Marconi, Carlo Pincelli

Summary: Pemphigus is a life-threatening autoimmune bullous disease that affects the skin and mucous membranes. Current therapies aim to suppress the immune system, but PC111, a fully human monoclonal antibody targeting Fas ligand, has shown promising results in reducing blister formation. In vitro and in vivo experiments have confirmed the mechanism of action and efficacy of PC111 in preventing acantholysis.

FRONTIERS IN IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

3D human foreskin model for testing topical formulations of sildenafil citrate

Greta Camilla Magnano, Marika Quadri, Elisabetta Palazzo, Roberta Lotti, Francesca Loschi, Stefano Dall'Acqua, Michela Abrami, Francesca Larese Filon, Alessandra Marconi, Dritan Hasa

Summary: This study aimed to investigate the loading of sildenafil citrate in three commercial transdermal vehicles using 3D full-thickness skin equivalent and compare the results with permeability experiments using porcine skin. The results showed that the results obtained using the 3D skin equivalent were comparable to those obtained using porcine skin, suggesting that the 3D skin model can be a valid alternative for ex-vivo skin absorption experiments.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2024)

No Data Available